Grants and Contributions:
Title:
Building a screening platform for the identification and development of unique metallotherapeutics
Agreement Number:
997677
Agreement Value:
$740,700.00
Agreement Date:
Oct 1, 2022 - Jan 31, 2025
Description:
The project goal is to build and validate a screening platform for identification of metal-based anticancer therapeutics with unique and promising characteristics for subsequent development.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6B 2Z4
Reference Number:
172-2022-2023-Q3-997677
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
748003712
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days. The total amended value is 64,000 dollars.
Amendment Date
Sep 26, 2024
Recipient's Legal Name:
Bold Therapeutics Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: